Skip to main content

Table 3 Absorbed dose metrics MAD, D50, D70 (Gy/GBq) and V120 (%) compared between simulation (99mTc-MAA) and therapy (90Y) for TL divided by tumoral volume

From: Predictive value of 99mTc-MAA-based dosimetry in personalized 90Y-SIRT planning for liver malignancies

Segment

Metric

99mTc-MAA

90Y

Pearson's r correlation

Relative difference (%)

Mean [range]

TL ≤ 200 ml

(n = 25)

MAD (Gy/GBq)

116.09 ± 101.75

90.23 ± 65.95

0.95 (P < .001)

28.27 [− 47.32–170.38]

D50 (Gy/GBq)

98.36 ± 77.36

85.08 ± 66.31

0.95 (P < .001)

19.30 [− 51.72–203.41]

D70 (Gy/GBq)

79.17 ± 72.02

69.39 ± 54.67

0.95 (P < .001)

9.86 [− 58.99–110.75]

V120 (%)

34.72 ± 25.28

30.16 ± 23.48

0.90 (P < .001)

TL > 200 ml

(n = 39)

MAD (Gy/GBq)

54.91 ± 31.71

43.84 ± 23.71

0.91 (P < .001)

23.70 [− 31.90–125.64]

D50 (Gy/GBq)

44.06 ± 28.39

39.98 ± 23.09

0.90 (P < .001)

8.80 [− 63.17–98.48]

D70 (Gy/GBq)

28.17 ± 19.50

30.20 ± 18.54

0.86 (P < .001)

− 7.00 [− 78.95–78.14]

V120 (%)

15.88 ± 11.35

12.16 ± 10.88

0.71 (P < .001)

  1. Wilcoxon’s p-value is higher than 0.05 for all metrics